CD8A and cancer: Nonetheless, a simple and readily available biomarker has gained widespread clinical applicability in a recent study on surgically resected colon cancer, wherein the interaction between FAP+ fibroblasts and CD8+ T cells significantly facilitated the cancer diagnosis (17).